EP2849788
PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) INHIBITORS FOR USE IN TREATING SEPSIS AND SEPTIC SHOCK
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.5.2013EP published:
3.1.2018EP application number:
13791248.1
EPO information:
European Patent Register
Max expiry date:
16.5.2033
Title:
PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) INHIBITORS FOR USE IN TREATING SEPSIS AND SEPTIC SHOCK
Timeline
Today
17.5.2013EP application
3.1.2018EP Publication
Owner
Name:
Cyon Therapeutics Inc.Address:
2500-700 West Georgia Street, Vancouver, British Columbia V7Y 1K8, CA
Inventor
Name:
WALLEY, Keith, R.Address:
North VancouverBritish Columbia V7N 4M9, CA
Name:
BOYD, John, HAddress:
VancouverBritish Columbia V6K 2A8, CA
Name:
RUSSELL, James, A.Address:
VancouverBritish Columbia V6M 1H8, CA
Priority
Number:
201261648319 PDate:
17.5.2012Country:
US
Classification
Categories:
A61K 39/395, A61K 31/4745, A61K 31/7088, A61K 38/17, A61P 29/00